science pharmaceutical expo biotech jobs

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiarugi, A.
Right arrow Articles by Moroni, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiarugi, A.
Right arrow Articles by Moroni, F.
(Journal of Leukocyte Biology. 2000;68:260-266.)
© 2000 by Society for Leukocyte Biology

Combined inhibition of indoleamine 2,3-dioxygenase and nitric oxide synthase modulates neurotoxin release by interferon-{gamma}-activated macrophages

Alberto Chiarugi*, Persio Dello Sbarba{dagger}, Alessandro Paccagnini{dagger}, Sandra Donnini*, Sandra Filippi* and Flavio Moroni*

* Department of Preclinical and Clinical Pharmacology and
{dagger} Department of Experimental Pathology and Oncology, University of Florence, Italy

Correspondence: Dr. Flavio Moroni, Dipartimento di Farmacologia Preclinica e Clinica, Università di Firenze, Viale Pieraccini 6, 50139 Firenze, Italy. E-mail: moronif{at}ds.unifi.it

We evaluated the synthesis of nitric oxide (NO) and of the neurotoxic kynurenine metabolites 3OH-kynurenine and quinolinic acid (QUIN) in interferon-{gamma} (IFN-{gamma})-activated macrophages of the murine BAC1.2F5 cell line with the aim of investigating the roles of mononuclear phagocytes in inflammatory neurological disorders. IFN-{gamma} induced indoleamine 2,3-dioxygenase (IDO) and NO synthase (NOS) and increased the synthesis of 3OH-kynurenine, QUIN, and NO that accumulated in the incubation medium where they reached neurotoxic levels. Macrophage exposure to norharmane, an IDO inhibitor, resulted in a decreased formation of not only the kynurenine metabolites but also NO. The inhibition of NO synthesis could not be ascribed to reduced NADPH availability or decreased NOS induction. Norharmane inhibited NOS activity also in coronary vascular endothelial cells and in isolated aortic rings. Our findings suggest that activated macrophages release large amounts of neurotoxic molecules and that norharmane may represent a prototype compound to study macrophage involvement in inflammatory brain damage.

Key Words: neuroinflammation • kynurenine pathway • nitric oxide • quinolinic acid • 3OH-kynurenine




This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas
Theiler's Virus Infection: a Model for Multiple Sclerosis
Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Chiarugi, E. Rovida, P. Dello Sbarba, and F. Moroni
Tryptophan availability selectively limits NO-synthase induction in macrophages
J. Leukoc. Biol., January 1, 2003; 73(1): 172 - 177.
[Abstract] [Full Text] [PDF]